Figure 3.

Public vs. TCRex-identified unique LLWNGPMAV-specific TCRs in the post-vaccination samples of Dewitt et al. (1) and Pogorelyy et al. (2). (A) Overview of the number of unique LLWNGPMAV-specific TCRs that were identified with TCRex in the post-vaccination PBMC samples for all nine volunteers (V1–V9) of Dewitt et al. (1) (dark blue) and the total number of public LLWNGPMAV-specific TCRs that were present in these repertoires (light blue). (B) Overview of the number of unique LLWNGPMAV-specific TCRs that were identified with TCRex in the post-vaccination PBMC samples for all six volunteers (P1–S2) of Pogorelyy et al. (2) (dark orange) and the total number of public LLWNGPMAV-specific TCRs that were present in these repertoires (light orange).